T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Edison International
EIX
$27.2B
| $37.1M | ﹤0.01% |
524,198
+3,834
| +0.7% | +$262K |
|
802
Commercial Metals
CMC
$7.98B
| $37.1M | ﹤0.01% |
630,836
+67,068
| +12% | +$3.55M |
|
803
Shift4
FOUR
$3.79B
| $37M | ﹤0.01% |
560,561
-117,222
| -17% | -$8.82M |
|
804
Reddit
RDDT
$30.4B
| $37M | ﹤0.01% |
+750,496
| New | +$41.1M |
|
805
Sana Biotechnology
SANA
$1.1B
| $37M | ﹤0.01% |
3,695,459
+101,434
| +3% | +$760K |
|
806
Infosys
INFY
$50.3B
| $36.9M | ﹤0.01% |
2,059,244
-89,480
| -4% | -$1.74M |
|
807
Atlas Energy Solutions
AESI
$1.47B
| $36.8M | ﹤0.01% |
1,628,485
+1,611,968
| +9,759% | +$30.1M |
|
808
Incyte
INCY
$24.4B
| $36.7M | ﹤0.01% |
643,656
-246,850
| -28% | -$14.8M |
|
809
Hewlett Packard
HPE
$79.2B
| $36.7M | ﹤0.01% |
2,067,721
+347,067
| +20% | +$5.64M |
|
810
Arm
ARM
$298B
| $36.4M | ﹤0.01% |
290,947
+14,584
| +5% | +$1.55M |
|
811
Boise Cascade
BCC
$2.94B
| $36.3M | ﹤0.01% |
236,980
+176,738
| +293% | +$23.9M |
|
|
GBIO
812
DELISTED
Generation Bio
GBIO
| $36.1M | ﹤0.01% |
887,836
+195,219
| +28% | +$4.6M |
|
813
T. Rowe Price
TROW
$23.7B
| $36M | ﹤0.01% |
295,449
+2,323
| +0.8% | +$259K |
|
814
HP
HPQ
$28.6B
| $36M | ﹤0.01% |
1,191,666
+15,675
| +1% | +$461K |
|
815
Monte Rosa Therapeutics
GLUE
$1.35B
| $35.9M | ﹤0.01% |
5,096,787
+155,880
| +3% | +$924K |
|
816
MacroGenics
MGNX
$259M
| $35.9M | ﹤0.01% |
2,438,050
+2,409,237
| +8,362% | +$36.4M |
|
817
Alpha Metallurgical Resources
AMR
$1.97B
| $35.8M | ﹤0.01% |
108,096
-34,546
| -24% | -$12.7M |
|
818
LyondellBasell Industries
LYB
$20.2B
| $35.7M | ﹤0.01% |
348,692
+3,583
| +1% | +$349K |
|
|
AUTL
819
Autolus Therapeutics
AUTL
$591M
| $35M | ﹤0.01% |
5,488,986
+2,487,778
| +83% | +$15.5M |
|
820
Entergy
ETR
$49.9B
| $34.7M | ﹤0.01% |
655,958
+8,794
| +1% | +$446K |
|
821
Brown & Brown
BRO
$24B
| $34.4M | ﹤0.01% |
393,272
-127,778
| -25% | -$10.3M |
|
822
Agilysys
AGYS
$3.25B
| $34M | ﹤0.01% |
403,153
+20,703
| +5% | +$1.67M |
|
823
Immatics
IMTX
$1.31B
| $33.9M | ﹤0.01% |
3,225,360
+891,191
| +38% | +$10.4M |
|
824
TKO Group
TKO
$14.6B
| $33.8M | ﹤0.01% |
390,877
+498
| +0.1% | +$41.5K |
|
|
CNTA
825
DELISTED
Centessa Pharmaceuticals
CNTA
| $33.4M | ﹤0.01% |
2,958,079
+418,615
| +16% | +$3.96M |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.